Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

alectinib

(uh-LEK-tih-nib)
A drug used to treat adults with certain types of non-small cell lung cancer that are ALK positive. It used in patients whose cancer has spread to other parts of the body. It is also used to help keep cancer from coming back in patients whose cancer was removed by surgery. Alectinib is also being studied in the treatment of other types of cancer. Alectinib blocks certain proteins made by the ALK gene, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called Alecensa.
Search NCI's Dictionary of Cancer Terms